Stocks
Nektar Therapeutics (NKTR) Debt/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 2.62 | 1.30 | 1.15 | 1.69 | 0.56 | 0.41 | ||
| Changes by years, y/y, % | +8% | -50% | -12% | +48% | -67% | |||
Nektar Therapeutics. Debt/EBITDA
Nektar Therapeutics. Debt/EBITDA, changes, %
Nektar Therapeutics (NKTR) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| Debt/EBITDA | 2.16 | 1.97 | 0.61 | 0.48 | 0.41 | 0.41 | ||
| Changes by years, y/y, % | +82% | +54% | -63% | -78% | -81% | |||
| Changes by quarters, q/q, % | -2% | -9% | -69% | -22% | -15% | |||
